Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases

Current treatments for central nervous system (CNS) inflammatory demyelinating diseases (IDDs) include corticosteroids, plasma exchange, intravenous immunoglobulin, and immunosuppressant drugs. However, some patients do not respond well to traditional therapies. In recent years, novel drugs, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Li, Guo, Shougang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647084/
https://www.ncbi.nlm.nih.gov/pubmed/36389702
http://dx.doi.org/10.3389/fimmu.2022.966766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647084/
https://www.ncbi.nlm.nih.gov/pubmed/36389702
http://dx.doi.org/10.3389/fimmu.2022.966766

Ejemplares similares